Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago. These

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to a loss of $0.46 per share a year ago. These

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates
Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago. These figures are

TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.21 per share a year ago

Intel's White House Reset: From Political Storm to a Clearer Sky
Intel's White House Reset: From Political Storm to a Clearer Sky

A multi-day rally for Intel Corporation (NASDAQ: INTC) this week has pushed shares back toward the $22 level, with a surge of over 5% on August 11 that continued to August 12. This newfound

These 3 Companies Shattered Quarterly Records
These 3 Companies Shattered Quarterly Records

The 2025 Q2 earnings cycle continues to wind down, with the vast majority of S&P 500 companies already delivering results. The period has been one of resilience, with overall growth remaining strong

Buying the Best Value Stocks as the Market Hits All-Time Highs
Buying the Best Value Stocks as the Market Hits All-Time Highs

The Nasdaq and the S&P 500 surged to new highs on Tuesday as Wall Street ramps up its bets on interest rate cuts after a slightly cooler-than-expected July inflation print.

The other market-moving

Uber’s $20B Buyback Could Spark a Trend—2 Stocks Already on Board
Uber’s $20B Buyback Could Spark a Trend—2 Stocks Already on Board

Uber Technologies (NYSE: UBER), the world’s leader in ride-sharing, just announced financial results that elicited a mixed reaction from market participants. However, Uber left no room for

Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside

For Sarepta Therapeutics (NASDAQ: SRPT), 2025 has been nothing short of an unmitigated disaster. The firm owns the only Food and Drug Administration (FDA)-approved gene therapy for the treatment

Air Lease Shares Up 4.8% Since Q2 Earnings & Revenues Top Estimates
Air Lease Shares Up 4.8% Since Q2 Earnings & Revenues Top Estimates

Shares of Air Lease Corporation (AL) have gained 4.8% since its second-quarter 2025 earnings release on Aug. 4, 2025. The uptick can be attributed to the better-than-expected earnings and revenue

Circle Internet Group, Inc. (CRCL) Reports Q2 Earnings: What Key Metrics Have to Say
Circle Internet Group, Inc. (CRCL) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Circle Internet Group, Inc. (CRCL) reported revenue of $658.08 million, representing no change compared to the same period last year. EPS came in at $1.02, compared

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

Cardinal Health (CAH) reported $60.16 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 0.5%. EPS of $2.08 for the same period compares to $1.84 a year

Sea Limited (SE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Sea Limited (SE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Sea Limited Sponsored ADR (SE) reported revenue of $5.36 billion, up 37.2% over the same period last year. EPS came in at $0.85, compared to $0.46 in the year-ago

Top Stock Picks for Week of August 11, 2025
Top Stock Picks for Week of August 11, 2025

Apple (AAPL) is one the world's leading tech juggernauts. The company is best known for its iPhone smartphone, which dominates the smartphone market, garnering more than a 50% market share in the

York Water (YORW) Beats Q2 Earnings and Revenue Estimates
York Water (YORW) Beats Q2 Earnings and Revenue Estimates

York Water (YORW) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.35 per share a year ago. These figures

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.29 per share a year ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates

Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.09 per share a year ago

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates

TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.28 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.28 per share a year ago. These figures are

Sotherly Hotels (SOHO) Lags Q2 FFO and Revenue Estimates
Sotherly Hotels (SOHO) Lags Q2 FFO and Revenue Estimates

Sotherly Hotels (SOHO) came out with quarterly funds from operations (FFO) of $0.21 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to FFO of $0.37 per share a year

Ondas Holdings Inc. (ONDS) Reports Q2 Loss, Beats Revenue Estimates
Ondas Holdings Inc. (ONDS) Reports Q2 Loss, Beats Revenue Estimates

Ondas Holdings Inc. (ONDS) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.14 per share a year ago. These

Madison Square Garden (MSGS) Reports Q4 Loss, Beats Revenue Estimates
Madison Square Garden (MSGS) Reports Q4 Loss, Beats Revenue Estimates

Madison Square Garden (MSGS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to earnings of $1.06 per share a year ago. These

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.45 per share a year ago

Paysafe Limited (PSFE) Meets Q2 Earnings Estimates
Paysafe Limited (PSFE) Meets Q2 Earnings Estimates

Paysafe Limited (PSFE) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.59 per share a year ago. These figures are

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates

Liquidia Technologies, Inc. (LQDA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.37 per share a year ago